СИНТЕЗ НОВЫХ НЕНАСЫЩЕННЫХ ТЕЛЛУРОРГАНИЧЕСКИХ СОЕДИНЕНИЙ С ПОТЕНЦИАЛЬНОЙ БИОЛОГИЧЕСКОЙ АКТИВНОСТЬЮ
Аннотация
Об авторах
М. В. МусаловаРоссия
В. А. Потапов
Россия
С. В. Амосова
Россия
Список литературы
1. Потапов В.А., Мусалова М.В., Амосова С.В. Синтез Е-2-хлорвинилтеллуртрихлорида и Е,Е-бис(2-хлорвинил)дителлурида // Изв. АН. Сер. хим. - 2012. - C. 201 -202.
2. Реакция тетрахлорида теллура с ацетиленом / В.А. Потапов, М.В. Мусалов, М.В. Мусалова, С.В. Амосова // Изв. АН. Сер. хим. — 2009. — C. 2327-2328.
3. A new immunomodulating compound (AS-101) with potential therapeutic application / B. Sredni, R.R. Caspi, A. Klein [et al.] // Nature. - 1987. -Vol. 330. - P. 173-176.
4. A novel organotellurium compound (RT-01) as a new antileishmanial agent / C.B.C. Lima, W.W. Arrais-Silva, R.L.O.R. Cunha, S. Giorgio // Korean J. Parasitol. - 2009. - Vol. 47. - P. 213-218.
5. Antioxidative properties of organotellurium compounds in cell systems / E. Wieslander, L. Engman, E. Svensjo [et al.] // Biochem. Pharmacol. - 1998. -Vol. 55. - P. 573-584.
6. Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium (IV) compound RT-04 / T.S. Abondanza, C.R. Oliveira, C.M. Barbosa [et al.] // Food Chem. Toxicol. - 2008. - Vol. 46. -P. 2540-2545.
7. Binding of tellurium to hepatocellular selenoproteins during incubation with inorganic tellurite: consequences for the activity of selenium-dependent glutathione peroxidase / P. Garberg, L. Engman, V. Tolmachev [et al.] // Int. J. Biochem. Cell. Biol. - 1999. - Vol. 31. - P. 291 -301.
8. Chasteen T.G., Bentley R. Biomethylation of selenium and tellurium: microorganisms and plants // Chem. Rev. - 2003. - Vol. 103. - P. 1-25.
9. Cytometric determination of novel organotellurium compound toxicity in a promyelocytic (HL-60) cell line / B.L. Sailer, N. Liles, S. Dickerson, T.G. Chasteen // Arch. Toxicol. 2003. - Vol. 77. -P. 30-36.
10. Nogueira C.W., Zeni G., Rocha J.B.T. Organoselenium and organotellurium compounds: toxicology and pharmacology // Chem. Rev. -2004. - Vol. 104. - P. 6255-6285.
11. Petragnani N., Stefani H.A. Tellurium in Organic Synthesis. - London: Academic Press, 2007. - 372 p.
12. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium (IV) compounds as inhibitors of human cathepsin B / R.L. Cunha, M.E. Urano, J.R. Chagas [et al.] // Bioorg. Med. Chem. Lett. - 2005. - Vol. 15. - P. 755-760.
13. The novel tellurium immunomodulator AS101 inhibits interleukin-10 production and p38 MAPK expression in atopic dermatitis / D. Sredni-Kenigsbuch, M. Shohat, B. Shohat [et al.] // J. Dermatol. Sci. 2008. - Vol. 50. - P. 232-235.
14. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia: studies on human and animal models / B. Sredni, R.H. Xu, M. Albeck [et al.] // Int. J. Cancer. - 1996. -Vol. 65. - P. 97-103.
15. Vinylic tellurides: from preparation to their applicability in organic synthesis / G. Zeni, D.S. Ludtke, R.B. Panatieri, A.L. Braga // Chem. Rev. - 2006. - Vol. 106. - P. 1032-1076.
Рецензия
Для цитирования:
Мусалова М.В., Потапов В.А., Амосова С.В. СИНТЕЗ НОВЫХ НЕНАСЫЩЕННЫХ ТЕЛЛУРОРГАНИЧЕСКИХ СОЕДИНЕНИЙ С ПОТЕНЦИАЛЬНОЙ БИОЛОГИЧЕСКОЙ АКТИВНОСТЬЮ. Acta Biomedica Scientifica. 2012;(2(2)):117-120.
For citation:
Musalova M.V., Potapov V.A., Amosova S.V. SYNTHESIS OF NOVEL UNSATURATED ORGANOTELLURIUM COMPOUNDS WITH POTENTIAL BIOLOGICAL ACTIVITY. Acta Biomedica Scientifica. 2012;(2(2)):117-120. (In Russ.)